Cell and gene therapies require extensive safety testing all the way from raw materials to commercial lot release. The inherent variability of biologics, small sample sizes and the need for rapid turn- around times all add to the complexity of the testing environment. Learn more about our cell and gene therapy testing offerings.
– The development of innovative advanced therapies represents a great opportunity to dramatically improve patients’ lives. However, the rapid and efficient production of these advanced therapies remains a considerable challenge. – Recent technological advancements in the process development of CAR-T cell therapy manufacturing. – A modular approach was used to optimize unit operations to build …Read More >
From clarification to separation of empty and full capsids, each downstream processing step has its challenges in viral vector manufacturing at a CDMO.
In this poster, we will discuss our recent technical advancement on efficient viral vector manufacturing process development.